Patents Assigned to Orient Pharma Co., Ltd.
  • Solid oral pharmaceutical composition
    Patent number: 11833133
    Abstract: A solid oral pharmaceutical composition is disclosed, which comprises: a first active ingredient, which is pitavastatin or a pharmaceutically acceptable salt thereof; a second active ingredient, which is ezetimibe or a pharmaceutically acceptable salt thereof; and at least one excipient, including a diluent, a stabilizing agent, a disintegrant, a binding agent, a sweetener, a lubricant, a glidant, a flavor, a coloring agent or a combination thereof.
    Type: Grant
    Filed: August 5, 2021
    Date of Patent: December 5, 2023
    Assignee: ORIENT PHARMA CO., LTD.
    Inventors: Chien-Yu Chen, David Wong, Mongkol Sriwongjanya
  • MULTI-LAYER CAPSULE AND MANUFACTURE METHOD THEREOF
    Publication number: 20150174009
    Abstract: The present invention provides multi-layer capsules and manufacture methods thereof Different materials are added in sequence into a capsule to form a multi-layer capsule without diffusion and/or interaction between layers.
    Type: Application
    Filed: June 15, 2011
    Publication date: June 25, 2015
    Applicant: Orient Pharma Co., Ltd.
    Inventors: Ikuo Goto, Chin-Chih Chiang, Yen-Fei Chen
  • STABLE FORMULATIONS OF PITAVASTATIN
    Publication number: 20130310420
    Abstract: Disclosed is a pharmaceutical composition comprising pitavastatin, or its salt or ester and MgO, of which the aqueous solution or dispersion has pH of from 10 to 10.8. The composition has good time-dependent stability and has no change in its outward appearance even after having been stored long.
    Type: Application
    Filed: April 17, 2013
    Publication date: November 21, 2013
    Applicant: ORIENT PHARMA CO., LTD.
    Inventors: Yu-Chien Hsiao, Chi-Tai Chang, Che-Chin Lin
  • COMBINATION OF ALPHA-2 RECEPTOR AGONIST (CLONIDIN) AND ANTI-MUSCARINIC AGENT (OXYBUTYNIN) FOR THE TREATMENT OF SIALORRHOEA
    Publication number: 20120316213
    Abstract: An alpha2 adrenoreceptor agonist eg. clonidine, brimonidine, monoxidine, lofexidine is useful for the treatment of siaiorrhoea, administered by the paraungual, sublingual or buccal route. The patient to be treated is also given an anti-muscarinic agent eg. oxybutynin, glycopyrrolate, ipratropium.
    Type: Application
    Filed: August 23, 2012
    Publication date: December 13, 2012
    Applicant: Orient Pharma Co., Ltd.
    Inventors: Alan Geoffrey Roach, Paul Goldsmith
  • Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds
    Publication number: 20090297591
    Abstract: The present invention is directed to compositions and methods for the transdermal delivery of a pharmaceutically active compound. In some embodiments, the addition of inert pharmaceutical ingredients in place of a portion of adhesive in a transdermal patch formulation increases the rate of skin permeation of a pharmaceutical compound.
    Type: Application
    Filed: May 14, 2009
    Publication date: December 3, 2009
    Applicant: Orient Pharma Co., Ltd.
    Inventors: Chin-Chih Chiang, Tse-Ching Lin, Remy Chen